Article: Addressing High Throughput and High Content Challenges in Drug Discovery

Traditional cell analysis platforms or dedicated single or multiplex assay systems are generally slow, offer limited analytic capabilities mandating the use of multiple platforms for comprehensive data production to meet the growing competitive pressure of the drug discovery market.

Learn how leading researchers from Dana Farber Cancer Institute, Takeda Pharmaceuticals, Kite Pharma, and LifeArc are addressing these challenges with an advanced flow cytometry platform. 


Complete the form to download

Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Please provide your information to download this resource

Ready to Buy?